Hsp60 and Hspl0 as antitumor molecular agents

Area of Science:

• Molecular biology
• Oncology
• Immunology

Background:

• Molecular chaperones heat shock protein 60 (Hsp60) and heat shock protein 10 (Hsp10) are increasingly recognized for their roles in cancer.
• Expression patterns of Hsp60 and Hsp10 differ across various malignancies, indicating tissue-specific involvement in carcinogenesis and progression.

Purpose of the Study:

• To highlight the dual role of Hsp60 and Hsp10 in cancer development and progression.
• To emphasize the therapeutic potential of Hsp60 and Hsp10 in oncology, drawing parallels with their use in other conditions like rheumatoid arthritis.

Main Methods:

• Analysis of existing literature and research findings on Hsp60 and Hsp10 expression in different cancer types.
• Review of evidence supporting the therapeutic applications of Hsp60 and Hsp10.

Main Results:

• Hsp60 and Hsp10 are overexpressed in colorectal, exocervical, and prostate carcinogenesis, and in colorectal cancer progression.
• Conversely, these chaperones are downregulated during bronchial carcinogenesis.
• Precedent exists for using Hsp60 and Hsp10 as therapeutic agents, notably in rheumatoid arthritis.

Conclusions:

• The distinct expression patterns of Hsp60 and Hsp10 in various cancers suggest their involvement in tumorigenesis.
• Hsp60 and Hsp10 represent promising candidates for novel cancer therapies.
• Further research into Hsp60 and Hsp10 mechanisms and therapeutic applications in cancer is warranted.